In AD, the enzymes acetylcholinesterase (AChE)and butyrylcholinesterase (BChE) play crucial roles in both its progressionand treatment. AChE inhibitors such asdonepezil, rivastigmine, and galantamine help increase ACh levels,thereby improving cognitive function in early to moderate AD. This evidence concerns the gene ACHE and Alzheimer disease.